The online version of this article (doi:10.1186/1475-2875-11-381) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
KCK, BDF, and JHR designed research, KCK performed research, KCK analysed data, KCK, BDF, and JHR wrote and edited the paper, JHR provided reagents. All authors read and approved the final manuscript.
When ingested in a blood meal, ivermectin has been shown to reduce the survivorship of Anopheles gambiae in the laboratory and field. Furthermore, ivermectin mass drug administrations in Senegal have been shown to reduce the proportion of Plasmodium falciparum-sporozoite-containing An. gambiae. This study addresses whether ivermectin inhibits sporogony of P. falciparum in An. gambiae.
Anophele gambiae s.s. G3 strain were fed two concentrations of ivermectin (LC25 and LC5) along with P. falciparum NF54 in human blood meals at staggered intervals. Mosquitoes ingested ivermectin concurrent with parasites (DPI 0), or at three (DPI 3), six (DPI 6), and nine (DPI 9) days post parasite ingestion, or three days prior (DPI −3) to parasite ingestion. Mosquitoes were dissected at seven, twelve or fourteen days post parasite ingestion and either oocyst or sporozoite prevalence was recorded. To determine if P. falciparum sporozoite-containing An. gambiae were more susceptible to ivermectin than uninfected controls, survivorship was recorded for mosquitoes which ingested P. falciparum or control blood meal on DPI 0 and then a second blood meal containing ivermectin (LC25) on DPI 14.
Ivermectin (LC25) co-ingested (DPI 0) with parasites reduced the proportion of An. gambiae that developed oocysts (χ2 = 15.4842, P = 0.0002) and sporozoites (χ2 = 19.9643, P < 0.0001). Ivermectin (LC25) ingested DPI 6 (χ2 = 8.5103, P = 0.0044) and 9 (χ2 = 14.7998, P < 0.0001) reduced the proportion of An. gambiae that developed sporozoites but not when ingested DPI 3 (χ2 = 0.0113, P = 1). Ivermectin (LC5) co-ingested (DPI 0) with parasites did not reduce the proportion of An. gambiae that developed oocysts (χ2 = 4.2518, P = 0.0577) or sporozoites (χ2 = 2.3636, P = 0.1540), however, when ingested DPI −3 the proportion of An. gambiae that developed sporozoites was reduced (χ2 = 8.4806, P = 0.0047). Plasmodium falciparum infection significantly reduced the survivorship of An. gambiae that ingested ivermectin (LC25) on DPI 14 compared to control mosquitoes that ingested a primary blood meal without parasites (χ2 = 4.97, P = 0.0257).
Ivermectin at sub-lethal concentrations inhibits the sporogony of P. falciparum in An. gambiae. These findings support the utility of ivermectin for P. falciparum transmission control.
Authors’ original file for figure 112936_2012_2531_MOESM1_ESM.tiff
Authors’ original file for figure 212936_2012_2531_MOESM2_ESM.tiff
Authors’ original file for figure 312936_2012_2531_MOESM3_ESM.tiff
Authors’ original file for figure 412936_2012_2531_MOESM4_ESM.tiff
Authors’ original file for figure 512936_2012_2531_MOESM5_ESM.tiff
Alonso PL, Besansky NJ, Burkot TR, Collins FH, Hemingway J, James AA, Lengeler C, Lindsay S, Liu Q, Lobo NF, Mnzava A, Tanner M, Zwiebel L: A research agenda for malaria eradication: Vector control. PLOS Med. 2011, 8: e1000401- CrossRef
Sylla M, Kobylinski KC, Gray M, Chapman PL, Sarr MD, Rasgon JL, Foy BD: Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors. Malar J. 2010, 9: e365-10.1186/1475-2875-9-365. CrossRef
Kane NS, Hirschberg B, Qian S, Hunt D, Thomas B, Brochu R, Ludmerer SW, Zheng YC, Smith M, Arena JP, Cohen CJ, Schmatz D, Warmke J, Cully DF: Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin. Proc Natl Acad Sci U S A. 2000, 97: 13949-13954. 10.1073/pnas.240464697. PubMedCentralCrossRefPubMed
Hemingway J, Ranson H: Chemical control of vectors and mechanisms of resistance. Biology of disease vectors. Edited by: Marquardt WC. 2005, San Diego: sElsevier Academic Press, 627-647. 2
Curtis CF, Jana-Kara B, Maxwell CA: Insecticide treated nets: impact on vector populations and relevance of initial intensity of transmission and pyrethroid resistance. J Vector Borne Dis. 2003, 40: 1-8. PubMed
Black WCI, Moore CG: Population biology as a tool to study vector-borne diseases. Biology of disease vectors. Edited by: Marquardt WC. 2005, San Diego, CA: Elsevier Academic Press, 187-206. Second edition
Kiszewski A, Mellinger A, Spielman A, Malaney P, Sachs SE, Sachs J: A global index representing the stability of malaria transmission. Am J Trop Med Hyg. 2004, 70: 486-498. PubMed
SAS Institute I: SAS Version 9.2. 2002, Cary, NC
Duce IR, Scott RH: GABA sensitivity in the distal bundles of the locust extensor tibiae muscle. J Physiol. 1983, 343: 31-32. CrossRef
Ludmerer SW, Warren VA, Williams BS, Zheng YC, Hunt DC, Ayer MB, Wallace MA, Chaudhary AG, Egan MA, Meinke PT, Dean DC, Garcia ML, Cully DF, Smith MM: Ivermectin and nodulisporic acid receptors in Drosophila melanogaster contain both gamma-aminobutyric acid-gated Rdl and glutamate-gated GluCl alpha chloride channel subunits. Biochemistry. 2002, 41: 6548-6560. 10.1021/bi015920o. CrossRefPubMed
Nasveld P, Russell B, Kotecka B, Rieckmann K: Lack of in vitro effect of ivermectin on Plasmodium falciparum. Southeast Asian J Trop Med Public Health. 2003, 34: 552-553. PubMed
Elkassaby MH: Ivermectin uptake and distribution in the plasma and tissue of Sudanese and Mexican patients infected with Onchocerca volvulus. Trop Med Parasitol. 1991, 42: 79-81. PubMed
Lariviere M, Beauvais B, Aziz M, Garin YJF, Abeloos J, Derouin F, Bamba M, Bosseboeuf C, Ferlytherizol M, Sarfati C, Basset D, Basset A, Toure Y, Song D, Gaxotte P: Study in Ivory Coast (1985–1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. 1. a double-blind comparative study of 200 patients treated with a single oral dose of 100 mcg/kg, 150 mcg/kg or 200 mcg/kg. Bull Soc Pathol Exot. 1989, 82: 35-47.
Burg RW, Stapley EO: Isolation and characterization of the producing organism. Ivermectin and abamectin. Edited by: Campbell WC. 1989, New York, New York: Springer, 24-32. CrossRef
Mastrangelo E, Pezzullo M, De Burghgraeve T, Kaptein S, Pastorino B, Dallmeier K, de Lamballerie X, Neyts J, Hanson AM, Frick DN, Bolognesi M, Milani M: Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J Antimicrob Chemother. 2012, 67: 1884-1894. 10.1093/jac/dks147. PubMedCentralCrossRefPubMed
Smith RC, Jacobs-Lorena M: Plasmodium-mosquito interactions: A tale of roadblocks and detours. Advances in Insect Physiology, Vol 39. Volume 39. Edited by: Simpson SJ. 2010, London: Academic Press Ltd-Elsevier Science Ltd, 119-149. CrossRef
Chege GMM, Beier JC: Immunodetection of Plasmodium falciparum zygotes and ookinetes in Anopheles blood meals. J Am Mosq Control Assoc. 1994, 10: 419-422. PubMed
Rossignol PA, Ribeiro JMC, Spielman A: Increased intradermal probing time in sporozoite-infected mosquitoes. Am J Trop Med Hyg. 1984, 33: 17-20. PubMed
Wekesa JW, Copeland RS, Mwangi RW: Effect of Plasmodium falciparum on blood feeding behavior of naturally infected Anopheles mosquitoes in Western Kenya. Am J Trop Med Hyg. 1992, 47: 484-488. PubMed
Koella JC, Packer MJ: Malaria parasites enhance blood-feeding of their naturally infected vector Anopheles punctulatus. Parasitol. 1996, 113: 105-109. 10.1017/S0031182000066348. CrossRef
Koella JC, Sorensen FL, Anderson RA: The malaria parasite, Plasmodium falciparum, increases the frequency of multiple feeding of its mosquito vector, Anopheles gambiae. Proc R Soc Lond Ser B-Biol Sci. 1998, 265: 763-768. 10.1098/rspb.1998.0358. CrossRef
Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, Sutherland C, Sauerwein R, Ghani AC, Drakeley C: Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J. 2010, 9: e136-10.1186/1475-2875-9-136. CrossRef
Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, Deen J, Pinder M, Doherty T, Sutherland C, Walraven G, Milligan P: Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis. 2001, 183: 1254-1259. 10.1086/319689. CrossRefPubMed
Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, Alexander N, Coleman R, Pinder M, Walraven G, Targett GAT: Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLOS Med. 2005, 2: 338-346. 10.1371/journal.pmed.0020338. CrossRef
Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ: Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J. 2008, 7: e125-10.1186/1475-2875-7-125. CrossRef
Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T: Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLOS Clin Trials. 2007, 2: e1023-
Reeve PA, Toaliu H, Kaneko A, Hall JJ, Ganczakowski M: Acute intravascular hemolysis in Vanuatu following a single dose of primaquine in individuals with glucose-6-phosphate-dehydrogenase deficiency. J Trop Med Hyg. 1992, 95: 349-351. PubMed
- Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae
Kevin C Kobylinski
Brian D Foy
Jason H Richardson
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II